company background image
EMV

EMvision Medical DevicesASX:EMV Stock Report

Market Cap

AU$212.0m

7D

-1.0%

1Y

3.5%

Updated

26 Oct, 2021

Data

Company Financials
EMV fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

EMV Overview

EMvision Medical Devices Limited, a medical device company, engages in the research, development, and commercialization of imaging and diagnostic technology products.

Price History & Performance

Summary of all time highs, changes and price drops for EMvision Medical Devices
Historical stock prices
Current Share PriceAU$2.94
52 Week HighAU$2.10
52 Week LowAU$4.20
Beta1.69
1 Month Change-1.34%
3 Month Change12.64%
1 Year Change3.52%
3 Year Changen/a
5 Year Changen/a
Change since IPO863.93%

Recent News & Updates

Oct 04
We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate

We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Jun 08
We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate

We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate

Just because a business does not make any money, does not mean that the stock will go down. Indeed, EMvision Medical...

Feb 22
Here's Why We're Not Too Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Situation

Here's Why We're Not Too Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Situation

There's no doubt that money can be made by owning shares of unprofitable businesses. By way of example, EMvision...

Shareholder Returns

EMVAU Medical EquipmentAU Market
7D-1.0%0.3%0.8%
1Y3.5%-7.4%24.4%

Return vs Industry: EMV exceeded the Australian Medical Equipment industry which returned -7.4% over the past year.

Return vs Market: EMV underperformed the Australian Market which returned 24.4% over the past year.

Price Volatility

Is EMV's price volatile compared to industry and market?
EMV volatility
EMV Beta1.69
Industry Beta0.57
Market Beta1

Stable Share Price: EMV is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: EMV's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2017n/aRon Weinbergerhttps://www.emvision.com.au

EMvision Medical Devices Limited, a medical device company, engages in the research, development, and commercialization of imaging and diagnostic technology products. It develops a portable brain scanner for point of care, stroke diagnosis, and monitoring. The company was incorporated in 2017 and is based in Macquarie Park, Australia.

EMvision Medical Devices Fundamentals Summary

How do EMvision Medical Devices's earnings and revenue compare to its market cap?
EMV fundamental statistics
Market CapAU$211.98m
Earnings (TTM)-AU$8.40m
Revenue (TTM)AU$1.70m

Earnings & Revenue

Key profitability statistics from the latest earnings report
EMV income statement (TTM)
RevenueAU$1.70m
Cost of RevenueAU$0
Gross ProfitAU$1.70m
ExpensesAU$10.10m
Earnings-AU$8.40m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.11
Gross Margin100.00%
Net Profit Margin-494.36%
Debt/Equity Ratio0%

How did EMV perform over the long term?

See historical performance and comparison

Valuation

Is EMvision Medical Devices undervalued compared to its fair value and its price relative to the market?

21.38x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate EMV's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate EMV's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: EMV is unprofitable, so we can't compare its PE Ratio to the Australian Medical Equipment industry average.

PE vs Market: EMV is unprofitable, so we can't compare its PE Ratio to the Australian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate EMV's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: EMV is overvalued based on its PB Ratio (21.4x) compared to the AU Medical Equipment industry average (4.5x).


Future Growth

How is EMvision Medical Devices forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

14.1%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as EMvision Medical Devices has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has EMvision Medical Devices performed over the past 5 years?

-56.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: EMV is currently unprofitable.

Growing Profit Margin: EMV is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: EMV is unprofitable, and losses have increased over the past 5 years at a rate of 56.6% per year.

Accelerating Growth: Unable to compare EMV's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: EMV is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (74.9%).


Return on Equity

High ROE: EMV has a negative Return on Equity (-83.54%), as it is currently unprofitable.


Financial Health

How is EMvision Medical Devices's financial position?


Financial Position Analysis

Short Term Liabilities: EMV's short term assets (A$10.0M) exceed its short term liabilities (A$676.2K).

Long Term Liabilities: EMV's short term assets (A$10.0M) exceed its long term liabilities (A$43.8K).


Debt to Equity History and Analysis

Debt Level: EMV is debt free.

Reducing Debt: EMV had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: EMV has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: EMV has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 46.5% each year.


Dividend

What is EMvision Medical Devices's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate EMV's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate EMV's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if EMV's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if EMV's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of EMV's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.0yrs

Average management tenure


CEO

Ron Weinberger

no data

Tenure

AU$2,596,390

Compensation

Dr. Ronald Peter Weinberger, also known as Ron, BSc (Hons), Ph D., AIMM, serves as Chief Executive Officer of EMvision Medical Devices Limited and serves as its Managing Director since May 6, 2020. Dr. Wei...


CEO Compensation Analysis

Compensation vs Market: Ron's total compensation ($USD1.95M) is above average for companies of similar size in the Australian market ($USD554.70K).

Compensation vs Earnings: Ron's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: EMV's management team is not considered experienced ( 1 years average tenure), which suggests a new team.


Board Members

Experienced Board: EMV's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.1%.


Top Shareholders

Company Information

EMvision Medical Devices Limited's employee growth, exchange listings and data sources


Key Information

  • Name: EMvision Medical Devices Limited
  • Ticker: EMV
  • Exchange: ASX
  • Founded: 2017
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: AU$211.981m
  • Shares outstanding: 73.10m
  • Website: https://www.emvision.com.au

Location

  • EMvision Medical Devices Limited
  • 65 Epping Road
  • Suite 4.01
  • Macquarie Park
  • New South Wales
  • 2113
  • Australia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/26 07:01
End of Day Share Price2021/10/26 00:00
Earnings2021/06/30
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.